LIFECORE BIOMEDICAL, INC. \DE\ — Director's Dealing 2012

Nov 20, 2012

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: LANDEC CORP \CA\ (LNDC)
CIK: 0001005286
Period of Report: 2012-11-13

Reporting Person: Sohn Catherine A. (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Nonstatutory Stock Options(Right to buy)	$9.01	2019-11-13	Common Stock (10000)		Direct
Restricted Stock Unit (RSU)	$		Common Stock (3333)		Direct

Footnotes

F1: Restricted Stock Units will vest on the 3rd anniversary of the grant date and will be automatically settled in shares of common stock subject to vesting at a rate of 1 share per unit.

F2: The Restricted Stock Units convert into Common Stock of Landec Corporation on a 1 for 1 basis.